ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Critical Overview of Systematic Reviews of Shenfu Injection for Heart Failure

Huang, Jinke; Wang, Yanlu; Huang, Suihe; Qin, Xiaohui; Yan, Fang; Shen, Min; Huang, Yong*广东省人民医院; 广州中医药大学; 南方医科大学; 1; y
Cardiovascular Therapeutics2021-3-8DOI: 10.1155/2021/8816590
9被引6阅读
引用收藏
分享

摘要

Objectives. Shenfu Injection (SFI) was widely used in the treatment of heart failure (HF) in China. A plethora of systematic reviews/meta-analyses (SRs/MAs) has been conducted in this research area, although with scattered results. The purpose of this overview was to conduct a comprehensive review to summarize and critically evaluate the existing evidence. Methods. Digital databases were searched for SRs/MAs up to January 28, 2021. Two authors independently screened the reviews and assessed the methodological quality of included SRs/MAs using Assessing the Methodological Quality of Systematic Reviews 2 (AMSTAR-2). Quality of evidence for outcomes evaluated within the reviews was appraised with the Grading of Recommendation, Assessment, Development, and Evaluation (GRADE). Results. Thirteen SRs/MAs met the inclusion criteria. Based on AMSTAR-2, the quality of all SRs/MAs was critically low, because all of them have more than one critical domains that were unmet. Based on GRADE, the evidence quality of 24 outcome measures was low or very low, 27 outcome measures was moderate, and none outcome measure was high. Descriptive analysis showed that SFI was an effective and safe method for HF. Conclusions. The use of SFI for the treatment of HF may be clinically effective and safe. However, this conclusion must be interpreted cautiously due to the generally low methodological quality and low evidence quality of the included SRs/MAs. More rigorously designed SRs/MAs and RCTs with high methodological quality are necessary for further proof.

相关
加载中…
  • Efficacy and Safety of Shenfu Injection on Acute Heart Failure: A Systematic Review and Meta-Analysis
    Tao, Lanting; Mo, Zhaofan; Li, Zunjiang; Li, Shuang; Luo, Ziqing; Li, Dongli; Wang, Dawei; Zhu, Wei*; Ding, Banghan*PHYTOMEDICINE, 2023, 110: 154641.被引 2
  • Efficacy and safety of Shenfu injection for the treatment of post-acute myocardial infarction heart failure: A systematic review and meta-analysis
    Wu, Yanhua; Li, Shuang; Li, Zunjiang; Mo, Zhaofan; Luo, Ziqing; Li, Dongli; Wang, Dawei; Zhu, Wei*; Ding, Banghan*Frontiers in Pharmacology, 2022, 13: 1027131.被引 1
  • The role of Qishen Yiqi dripping pills in treating chronic heart failure: An overview of systematic reviews and meta-analyses
    Chen, Wensheng; Chen, Jiezhen; Wang, Yuanping; Yan, Jiaqi; Yan, Xia; Wang, Dawei*; Liu, Yuntao*Frontiers in Cardiovascular Medicine, 2022, 9: 1001072.被引 3
查看全部 →

发表信息

论文状态
公开发表
期刊
Cardiovascular Therapeutics
发表日期
2021-03-08
卷期
第 2021 卷
页码
8816590
DOI
10.1155/2021/8816590
语言
ENGLISH
期刊收录
NSL
期刊等级
4区
成果收录
SCIE

作者

  • H

    Huang, Jinke (第一作者)

    2 · guangzhou univ chinese med

  • W

    Wang, Yanlu

    1 · shandong univ tradit chinese med

查看全部 7 位作者收起作者
  • H

    Huang, Suihe

    guangdong prov hosp

  • Q

    Qin, Xiaohui

    guangdong prov hosp

  • Y

    Yan, Fang

    guangdong prov hosp

  • S

    Shen, Min

    2 · guangzhou univ chinese med

  • H

    Huang, Yong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417